<DOC>
	<DOCNO>NCT00852202</DOCNO>
	<brief_summary>The purpose study evaluate efficacy , safety , tolerability cariprazine treatment outpatient bipolar depression .</brief_summary>
	<brief_title>Safety Efficacy RGH-188 ( Cariprazine ) Bipolar Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<criteria>Men woman , 1865 year old Currently meet DSMIVTR criterion Bipolar I II Disorder without psychotic feature , current depressive episode A verify previous manic , hypomanic , mixed episode Score 20 high HAMD17 Score 2 high Item 1 HAMD Score great 12 Young Mania Rating Scale Eight episode mood disturbance ( depression , mania , hypomania , mixed state ) within 12 month prior Visit 1 Principal DSMIVTRbased diagnosis axis I disorder bipolar disorder ( secondary diagnosis comorbid Generalized Anxiety Disorder , Social Anxiety Disorder , specific phobia acceptable )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>bipolar</keyword>
	<keyword>depression</keyword>
</DOC>